What Do Blood and Plasma Donors Think About Biobanking? A New Study Reveals Their Attitudes
Karlijn Joosten, Staff Member Research and Development of Ambulance Care at RAVHM, posted on LinkedIn:
“I am proud to present you my first peer-reviewed publication, after a long period of perseverance.
Title: Attitudes of blood and plasma donors towards biobanking for longitudinal health research”
Authors: Karlijn F. Joosten, Lotte van Dammen, Eva-Maria Merz, Věra M. J. Novotný, Daphne C. Thijssen-Timmer, Katja van den Hurk
The article has been published in PLOS One last month.
In this article we investigated the attitudes of Sanquin blood and plasma donors towards the collection and storage of donation remainders in a future biobank. Together with questionnaire data this would give great opportunities for longitudinal health research.
With special thanks to Lotte van Dammen and Katja van den Hurk, and the other co-authors Eva-Maria Merz, Věra M.J. Novotný and Daphne Thijssen-Timmer.”
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’